Ticker Information
Ticker
DGXCompany Name
QUEST DIAGNOSTICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NYSEQUEST DIAGNOSTICS INC - EBITDA Margin Chart Analysis (TTM)
Date Range
Zoom
DGX - EBITDA Margin Historical Data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Revenues | EBITDA Margin |
|---|---|---|---|
| 2026-03-31 | $ 2.19B | $ 11.28B | 19.42% |
| 2025-12-31 | $ 2.14B | $ 11.04B | 19.39% |
| 2025-09-30 | $ 2.1B | $ 10.85B | 19.31% |
| 2025-06-30 | $ 2.03B | $ 10.52B | 19.29% |
| 2025-03-31 | $ 1.91B | $ 10.16B | 18.75% |
| 2024-12-31 | $ 1.84B | $ 9.87B | 18.62% |
| 2024-09-30 | $ 1.73B | $ 9.54B | 18.13% |
| 2024-06-30 | $ 1.71B | $ 9.35B | 18.28% |
| 2024-03-31 | $ 1.7B | $ 9.29B | 18.34% |
| 2023-12-31 | $ 1.69B | $ 9.25B | 18.3% |
QUEST DIAGNOSTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
| Company | EBITDA % |
|---|---|
| LH : LABCORP HOLDINGS INC | 16.04% |
| MTD : METTLER TOLEDO INTERNATIONAL INC | 30.67% |
| ILMN : ILLUMINA INC | 32.55% |
| IQV : IQVIA HOLDINGS INC | 21.39% |
| EXAS : EXACT SCIENCES CORP | 2.59% |
| A : AGILENT TECHNOLOGIES INC | 25.82% |
| BIIB : BIOGEN INC | 24.47% |
| VTRS : VIATRIS INC | 16.96% |
| NTRA : NATERA INC | -8.24% |
| ZBH : ZIMMER BIOMET HOLDINGS INC | 27.45% |
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %EBITDA % for QUEST DIAGNOSTICS INC is calculated as follows:
EBITDA [ $ 2.19B ] / Revenues [ $ 11.28B ]
(=) EBITDA % [ 19.42% ] EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 17.39% with a standard deviation of 27.17%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.21K |
|---|---|
| min | -76.4% |
| max | 100.17% |
| average | 17.39% |
| median | 15.54% |
| std | 27.17% |